TY - JOUR
T1 - FDA advisers warn of more deaths if drug is relaunched.
AU - Moynihan, Ray
PY - 2002/9/14
Y1 - 2002/9/14
N2 - Advisers to the US Food and Drug Administration are warning of more serious injuries and drug related deaths if alosetron (Lotronex)—a drug for bowel disorders manufactured by GlaxoSmithKline—returns to the market later this year.
AB - Advisers to the US Food and Drug Administration are warning of more serious injuries and drug related deaths if alosetron (Lotronex)—a drug for bowel disorders manufactured by GlaxoSmithKline—returns to the market later this year.
UR - http://www.scopus.com/inward/record.url?scp=19044361897&partnerID=8YFLogxK
U2 - 10.1136/bmj.325.7364.561
DO - 10.1136/bmj.325.7364.561
M3 - Article
C2 - 12228121
AN - SCOPUS:19044361897
SN - 0959-535X
VL - 325
SP - 561
EP - 561
JO - BMJ (Clinical research ed.)
JF - BMJ (Clinical research ed.)
IS - 7364
ER -